Amundi’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,766
| Closed | -$12.8K | – | 2026 |
|
|
2025
Q1 | $12.8K | Hold |
10,766
| – | – | ﹤0.01% | 1874 |
|
|
2024
Q4 | $22.6K | Buy |
+10,766
| New | +$22.6K | ﹤0.01% | 1881 |
|
|
2024
Q2 | – | Sell |
-112,869
| Closed | -$165K | – | 2004 |
|
|
2024
Q1 | $165K | Hold |
112,869
| – | – | ﹤0.01% | 1676 |
|
|
2023
Q4 | $867K | Sell |
112,869
-47,086
| -29% | -$362K | ﹤0.01% | 1349 |
|
|
2023
Q3 | $1.28M | Buy |
159,955
+60,365
| +61% | +$482K | ﹤0.01% | 1265 |
|
|
2023
Q2 | $1.28M | Buy |
99,590
+99,226
| +27,260% | +$1.28M | ﹤0.01% | 1237 |
|
|
2023
Q1 | $3.99K | Sell |
364
-9,035
| -96% | -$99K | ﹤0.01% | 2015 |
|
|
2022
Q4 | $92.9K | Sell |
9,399
-8,704
| -48% | -$86K | ﹤0.01% | 1618 |
|
|
2022
Q3 | $118K | Sell |
18,103
-5
| -0% | -$33 | ﹤0.01% | 1525 |
|
|
2022
Q2 | $84K | Buy |
18,108
+17,725
| +4,628% | +$82.2K | ﹤0.01% | 1475 |
|
|
2022
Q1 | $3K | Sell |
383
-113,857
| -100% | -$892K | ﹤0.01% | 1617 |
|
|
2021
Q4 | $1.51M | Sell |
114,240
-152,141
| -57% | -$2.01M | ﹤0.01% | 1228 |
|
|
2021
Q3 | $6.81M | Sell |
266,381
-181,712
| -41% | -$4.64M | ﹤0.01% | 930 |
|
|
2021
Q2 | $15.7M | Buy |
+448,093
| New | +$15.7M | 0.01% | 736 |
|